Bcr/abl recombinant DNA analysis versus karyotype diagnosis therapeutic monitoring chronic myeloid leukemia Karyotype bcr/abl recombinant DNA analyses means chromosomal aberration chronic myeloid leukemia authors methods retrospective study patients CML bcr/abl DNA recombinant event patients Philadelphia chromosome sensitivity battery bcr probes restriction enzymes necessary authors sequential algorithm efficient use probes enzymes patients bcr/abl rearrangement Bgl II digest commercial probe additional patients second assay membrane combination probe patient additional restriction enzyme digest BamH recombinant event probe Karyotype analysis cytogenetic remission patients CML therapy authors use DNA analysis Southern blot technique decrease relative number leukemic cells dilution studies densitometric scanning autoradiographs authors able decrease relative number cells bcr/abl recombinant event authors preliminary results patients karyotype recombinant DNA analysis multiple time points clinical course conclusion bcr/abl recombinant DNA analysis superior diagnosis CML monitoring treated patients 